Shinhan Investment Corp., KTB Growth Industry Hedge Fund, KTB Mezzanine Private Investment Trust No. 73 and KTB Mezzanine Private Investment Trust No. 74 funds managed by KTB Asset Management Co., Ltd acquired 3.92% in Km Pharmaceutical Co., Ltd. from Mun, Sung Keun for KRW 2 billion.
May 22, 2017
Share
Shinhan Investment Corp., KTB Growth Industry Hedge Fund, KTB Mezzanine Private Investment Trust No. 73 and KTB Mezzanine Private Investment Trust No. 74 funds managed by KTB Asset Management Co., Ltd acquired 3.92% in Km Pharmaceutical Co., Ltd. (XKON:A237720) from Mun, Sung Keun for KRW 2 billion on May 18, 2017. As reported, Shinhan Investment Corp. acquired 0.04 million shares, KTB Growth Industry Hedge Fund acquired 0.02 million shares and KTB Mezzanine Private Investment Trust No. 73 and KTB Mezzanine Private Investment Trust No. 74 collectively acquired 0.02 million shares at KRW 22,600 per share.
Shinhan Investment Corp., KTB Growth Industry Hedge Fund, KTB Mezzanine Private Investment Trust No. 73 and KTB Mezzanine Private Investment Trust No. 74 funds managed by KTB Asset Management Co., Ltd completed the acquisition of 3.92% in Km Pharmaceutical Co., Ltd. (XKON:A237720) from Mun, Sung Keun on May 18, 2017.
KMPharmaceutical Co Ltd is a Korea-based company principally engaged in the manufacture and sale of personal products. The Company is principally engaged in the manufacture and sale of oral hygiene products such as toothpaste, toothbrushes and gargles for children and adults. The Company is engaged in the manufacture and sale of beauty care products such as shampoo, body wash, cosmetics as well as other daily necessities. In addition, the Company is also engaged in the real estate leasing.